Turtle Pharma | Contract Pharma

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Turtle Pharma | Contract Pharma

Search by

Turtle Pharma

Company Headquarters

A Wing, 505, Knox Plaza, Mumbai, MH, 400064, IN

Driving Directions Phone: View Phone

View website

Request more information from Turtle Pharma

Request more information from Turtle Pharma

Yes, Please subscribe me to your weekly eNewsletters and Alerts

Yes, I wish to receive special promotions and offers from your affiliates.

Yes, I would like to learn more about Turtle Pharma. Please contact me by Phone or Email

By completing this form, you are accepting our Terms of Use and Privacy Policy.

Categories from Turtle Pharma

Manufacturing, API

Manufacturing, API, High Potency

Related Content

cphi milan summit

Online Exclusives

Inside CPHI Milan’s New Sustainability Summit

Silvia Forroova shares how CPHI Milan’s new Sustainability Summit will bring pharma leaders together to tackle key sustainability challenges.

By: Charlie Sternberg

cp bio outsourcing

Breaking News

Contract Pharma Announces New Bio Outsourcing Conference in Cambridge

Two-day event will bring the biopharma outsourcing community together April 1-2, 2027.

Promotions & Moves

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer

Myers comes from OrsoBio, where he was Chief Medical Officer as well as Head of Development.

By: Patrick Lavery

Promotions & Moves

Codis Promotes Steven Facer to Chief Commercial Officer

Facer offers 30+ years of leadership experience across pharmaceuticals, medical devices, and packaging.

By: Charlie Sternberg

telix itm

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

By: Charlie Sternberg

The-Friday_Brief_Graphics_091826_840 x 454

Videos

The Friday Brief for September 18, 2026: Companies Expand in US & Europe

Hovione, Upperton, Piramal Pharma, Syntegon, Evonik, and Fareva opened or announced plans to build new facilities.

By: Patrick Lavery

quotient ai (1)

Trials & Filings

Quotient Sciences Reports AI Clinical Trial Milestone

Proprietary algorithm achieved a preset pharmacokinetic target during an ongoing modified-release formulation study.

By: Charlie Sternberg

1stbio sk biopjarma

Collaborations & Alliances

SK Biopharma, 1STBIO Sign Parkinson’s Drug Deal

The exclusive global licensing agreement covers 1ST-104 and includes upfront, milestone and royalty payments.

By: Charlie Sternberg

piramal solar panels (1)

Breaking News

Piramal Pharma Plans Solar Power Plant in UK

Ground-mounted plant will generate about 3,950 MWh annually.

By: Charlie Sternberg

clean heat

Collaborations & Alliances

Sanofi, UCB, Opella Join Clean Heat Program

Pharma companies back Secaro and ERM initiative to cut industrial heat emissions.

By: Charlie Sternberg

Ori Biotech IRO Platform

Collaborations & Alliances

Ori Biotech Lands 10-Year, $120M Commercial Cell Therapy Manufacturing Deal

The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.

By: Patrick Lavery

vantij su vfc

Breaking News

Asahi Kasei Launches VANTIJ SU-VFC Benchtop

New platform streamlines small-scale virus filtration for biopharma and gene therapy workflows.

By: Charlie Sternberg

syntegon osd

Breaking News

Syntegon Opens OSD Customer Center in Fellbach

Offers support to pharmaceutical and nutraceutical developers from the initial idea through to series production.

By: Charlie Sternberg

Adam Shaywitz SonoThera

Promotions & Moves

SonoThera Appoints Adam Shaywitz Chief Medical Officer

Shaywitz brings two decades of experience in the biopharmaceutical industry, most recently at BridgeBio.

By: Patrick Lavery

samsung biologics

Collaborations & Alliances

Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company

The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.

By: Charlie Sternberg